首页工具

登录

搜索结果

Search Results for " farnesoid "

22

抑制剂 & 化合物

3

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T1789	Obeticholic Acid 奥贝胆酸,INT-747,6-Ethylchenodeoxycholic acid,6-ECDCA	FXR; Autophagy	Autophagy; Metabolism
	Obeticholic Acid (6-ECDCA) 是一种选择性的，有口服活性的 FXR 激动剂，EC50为 99 nM。它可诱导细胞自噬，具有抗胆碱和抗炎作用。
T2601	Vidofludimus SC12267,4sc-101	Dehydrogenase; DNA/RNA Synthesis; Interleukin	Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism
	Vidofludimus (SC12267) 是一种新型的二氢乳清酸脱氢酶 (DHODH) 小分子抑制剂，可在不影响淋巴细胞增殖的条件下抑制IL-17的分泌。
T7886	Nidufexor	FXR; Autophagy	Autophagy; Metabolism
	Nidufexor 是一种可口服的法尼醇 X 受体激动剂，可研究非酒精性脂肪性肝炎。
T2233	GW 4064	FXR; Autophagy	Autophagy; Metabolism
	GW 4064 是一种有效的法尼醇 X 受体 (FXR) 激动剂，EC50为 65 nM。
T8471	Vonafexor EYP001,PLX007,pxl007	FXR; HBV	Metabolism; Microbiology/Virology
	Vonafexor (EYP001) 是一种法尼醇 X 受体激动剂，具有抗 HBV 作用。
T2015	Fexaramine	FXR; Autophagy	Autophagy; Metabolism
	Fexaramine 是小分子法尼醇 X 受体 (FXR) 激动剂，EC50为 25 nM，与天然化合物相比，亲和力提高了 100 倍。
T11428	Glyco-Obeticholic acid	FXR	Metabolism
	Glyco-obeticholic acid 是一种牛磺酸的特性代谢物。Obeticholic Acid 是口服具有活性的法尼样 X 受体激动剂。
T7436	Cilofexor	FXR; Autophagy	Autophagy; Metabolism
	Cilofexor 是一种法尼醇 X 受体激动剂，EC50为 43 nM。它抑制合成肽的结合，具有抗炎和抗纤维化作用。它可用于原发性硬化性胆管炎和非酒精性脂肪性肝炎的研究。
T11426	Gly-β-MCA	FXR	Metabolism
	Gly-β-MCA 是一种具有口服生物活性、肠道选择性和有效的法尼酯X受体 (FXR) 抑制剂，是一种胆汁酸，可用于研究肥胖和糖尿病。
T8818	TC-G 1005 (4-环丙基-3,4-二氢-1(2H)-喹喔啉基)[4-(2,5-二甲基苯氧基)-3-吡啶基]甲酮	GPCR19	GPCR/G Protein
	TC-G 1005 是具有口服活性的TGR5选择性激动剂，能够激活 hTGR5 (EC50:0.72 nM)和 mTGR5 (EC50:6.2 nM)。它能够减少小鼠体内葡萄糖水平。
T27315	Fexaramate
	Fexaramate is a potent, selective agonist of farnesoid X receptor.
T27316	Fexarine
	Fexarine is a potent, selective agonist of farnesoid X receptor.
T13093	Tauro-β-muricholic acid sodium T-βMCA sodium	FXR	Metabolism
	Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM).
T27492	GSK-8062 GSK 8062
	GSK-8062 is an agonist of farnesoid X receptor (FXR).
T69724	Cilofexor tromethamine
	Cilofexor, also known as GS-9674, is a farnesoid X receptor (FXR) agonist. The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC. In clinical study, cilofexor was well tolerated and led to significant improvements in liver biochemistries and markers of cholestasis in patients with PSC.
T2968L	Hyodeoxycholic acid sodium salt Sodium hyodeoxycholate,HDCA sodium
	Hyodeoxycholic acid sodium salt is a natural secondary bile acid. It improves high-density lipoprotein function, reduces farnesoid X receptor antagonist bile acids, and induces strong cytotoxicity, apoptosis, and IL-8 synthesis.
T37416	Tauro-α-muricholic Acid (sodium salt)
	Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary bile acid α-muricholic acid . TαMCA is common in rodents but has also been found in small amounts in human serum.
T11661	INT-767	FXR; GPCR19	GPCR/G Protein; Metabolism
	INT-767 是一种高效的法尼类固醇 X 受体 (FXR)/TGR5 双激动剂，可预防 NASH 并促进内脏脂肪棕色脂肪生成和线粒体功能，可用于研究非酒精性脂肪性肝炎。
T73414	EDP-305
	EDP-305是一种具有选择性的口服farnesoid X受体(FXR)激动剂，其EC50值分别为34 nM(CHO细胞嵌合性FXR)和8 nM(HEK细胞全长FXR)。该化合物展现了强大且持久的抗纤维化效果，并适用于原发性胆道胆管炎(PBC)与非酒精性脂肪性肝炎(NASH)的研究。
T83858	Tauro-Obeticholic Acid sodium Tauro-6-Ethylchenodeoxycholic Acid,Tauro-6-Ethyl-CDCA,Obeticholic Acid Taurine Conjugate,Tauro-OCA,T-ECDCA
	陶氏奥贝胆酸是奥贝胆酸的活性代谢物，属于法尼索德X受体(FXR)激动剂并且是熊脱氧胆酸的半合成衍生物。陶氏奥贝胆酸通过在肝脏中与牛磺酸结合形成，但可以通过肠道微生物被再次转换回奥贝胆酸。
T37414	CAY10771
	CAY10771 is a dual agonist of farnesoid X receptor (FXR) and peroxisome proliferator-activated receptor δ (PPARδ).1It activates FXR and PPARδ in reporter assays using HEK293T cells (EC50s = 0.94 and 1.5 μM, respectively) and is selective for these receptors over retinoic acid receptor α (RARα), retinoid X receptor α (RXRα), PPARα, PPARγ, and liver X receptor α (LXRα) at 10 μM. 1.Schierle, S., Neumann, S., Heitel, P., et al.Design and structural optimization of dual FXR/PPARδ activatorsJ. Med. Ch...
T70899	Vidofludimus hemicalcium 4sc-101 hemicalcium,SC12267 hemicalcium,4sc-101 hemicalcium ; SC12267 hemicalcium
	Vidofludimus (4sc-101 ; SC12267) hemicalcium 是一种口服有效的二氢乳清酸脱氢酶 (DHODH) 的抑制剂，也是法尼醇 X 受体 (FXR) 调节剂。Vidofludimus hemicalcium 作为一种免疫调节剂，可用于研究自身免疫性疾病，如炎症性肠病 (IBD)。Vidofludimus hemicalcium 还可通过靶向FXR 用于脂肪肝的研究。

化合物

Obeticholic Acid

Cat.No: T1789

Synonym: 奥贝胆酸,INT-747,6-Ethylchenodeoxycholic acid,6-ECDCA

Target: FXR, Autophagy

Cat.No: T2601

Synonym: SC12267,4sc-101

Target: Dehydrogenase, DNA/RNA Synthesis, Interleukin

Cat.No: T7886

Target: FXR, Autophagy

Cat.No: T2233

Target: FXR, Autophagy

Cat.No: T8471

Synonym: EYP001,PLX007,pxl007

Target: FXR, HBV

Cat.No: T2015

Target: FXR, Autophagy

Glyco-Obeticholic acid

Cat.No: T11428

Target: FXR

Cat.No: T7436

Target: FXR, Autophagy

Cat.No: T11426

Target: FXR

Cat.No: T8818

Synonym: (4-环丙基-3,4-二氢-1(2H)-喹喔啉基)[4-(2,5-二甲基苯氧基)-3-吡啶基]甲酮

Target: GPCR19

Cat.No: T27315

Cat.No: T27316

Tauro-β-muricholic acid sodium

Cat.No: T13093

Synonym: T-βMCA sodium

Target: FXR

Cat.No: T27492

Synonym: GSK 8062

Cilofexor tromethamine

Cat.No: T69724

Hyodeoxycholic acid sodium salt

Cat.No: T2968L

Synonym: Sodium hyodeoxycholate,HDCA sodium

Tauro-α-muricholic Acid (sodium salt)

Cat.No: T37416

Cat.No: T11661

Target: FXR, GPCR19

Cat.No: T73414

Tauro-Obeticholic Acid sodium

Cat.No: T83858

Synonym: Tauro-6-Ethylchenodeoxycholic Acid,Tauro-6-Ethyl-CDCA,Obeticholic Acid Taurine Conjugate,Tauro-OCA,T-ECDCA

Cat.No: T37414

Vidofludimus hemicalcium

Cat.No: T70899

Synonym: 4sc-101 hemicalcium,SC12267 hemicalcium,4sc-101 hemicalcium ; SC12267 hemicalcium

Cat. No.	Product Name	Target	Signaling Pathways
T13092	Tauro-Obeticholic acid	FXR	Metabolism
	Tauro-Obeticholic acid 是一种牛磺酸的特性代谢物。Obeticholic Acid 是口服具有活性的法尼样 X 受体激动剂。
T75538	Alismanol M
	Alismanol M，一种法尼酯 X 受体 (FXR) 激动剂，具有 50.25 μM 的 EC50 值。作为一种源自东方红根茎的原丹类三萜化合物，Alismanol M 主要应用于胆汁淤积与非酒精性脂肪性肝炎的研究。
T36563	(E)-Guggulsterone
	Bile acids are essential for solubilization and transport of dietary lipids, are the major products of cholesterol catabolism, and are physiological ligands for farnesoid X receptor (FXR), a nuclear receptor that regulates genes involved in lipid metabolism.1They are also inherently cytotoxic, as physiological imbalance contributes to increased oxidative stress.2,3Bile acid-controlled signaling pathways are promising novel targets to treat such metabolic diseases as obesity, type II diabetes, hy...

天然产物

Tauro-Obeticholic acid

Cat.No: T13092

Target: FXR

Cat.No: T75538

(E)-Guggulsterone

Cat.No: T36563

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼